FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2155210306> ?p ?o ?g. }

• W2155210306 endingPage "298" @default.
• W2155210306 startingPage "288" @default.
• W2155210306 abstract "Delayed hypersenstivity to streptokinase and tuberculin used as antigens, and the capacity to form antibodies to streptokinase, were investigated in various malignant blood diseases and the results were compared with those found in some other diseases and in a control group of healthy subjects. It was found that anergy similar to that seen in Hodgkin's disease (also confirmed in this work) can be found with regard to two antigens in reticulosarcoma, myeloma, acute leukaemia and chronic myelosis. In myelofibrosis partial anergy was observed only with streptokinase but not with tuberculin antigen. The anergy was in general not correlated with the absolute lymphocyte count in the peripheral blood nor with the treatment given. The increase in antistreptokinase antibodies after immunization with streptokinase was investigated. This administration of the antigen (secondary response) gave results which did not differ from those in controls in Hodgkin's disease, reticulosarcoma, acute leukaemia and chronic myelosis. In myeloma and especially in chronic lymphatic leukaemia, however, the antibody-forming capacity was significantly decreased. Thus, the results point to a dissociation in the immunological response: in Hodgkin's disease, reticulosarcoma, acute leukaemia and chronic myelosis, there is a significant decrease in the response of the cellular type with preservation of antibody-forming power. In myeloma both types of reactions are decreased. In chronic lymphatic leukaemia antibody-forming capacity is reduced with relatively good preservation of the cellular type of reactivity. Delayed hypersensitivity to tuberculin was also depressed in patients with sarcoidosis although tested during remission, whereas skin sensitivity to streptokinase was preserved. In patients with pancytopenia the delayed hypersensitivity was only slightly suppressed, but there was a tendency to produce higher antibody titres against streptokinase than in the controls, although the difference was not statistically significant. There were similar findings in patients with autoimmune haemolytic anaemia." @default.
• W2155210306 created "2016-06-24" @default.
• W2155210306 creator A5080756585 @default.
• W2155210306 date "1969-05-15" @default.
• W2155210306 modified "2023-09-27" @default.
• W2155210306 title "The investigation of the cellular type of immunity in patients with lymphoproliferative and myeloproliferative diseases" @default.
• W2155210306 cites W1981771797 @default.
• W2155210306 cites W1986778170 @default.
• W2155210306 cites W2027491033 @default.
• W2155210306 cites W2036919895 @default.
• W2155210306 cites W2036999962 @default.
• W2155210306 cites W2037264398 @default.
• W2155210306 cites W2053269284 @default.
• W2155210306 cites W2067454183 @default.
• W2155210306 cites W2083799162 @default.
• W2155210306 cites W2272635336 @default.
• W2155210306 cites W2338684119 @default.
• W2155210306 cites W2339836724 @default.
• W2155210306 cites W2414161893 @default.
• W2155210306 cites W31996395 @default.
• W2155210306 doi "https://doi.org/10.1002/ijc.2910040306" @default.
• W2155210306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/5801416" @default.
• W2155210306 hasPublicationYear "1969" @default.
• W2155210306 type Work @default.
• W2155210306 sameAs 2155210306 @default.
• W2155210306 citedByCount "4" @default.
• W2155210306 crossrefType "journal-article" @default.
• W2155210306 hasAuthorship W2155210306A5080756585 @default.
• W2155210306 hasConcept C126322002 @default.
• W2155210306 hasConcept C142724271 @default.
• W2155210306 hasConcept C147483822 @default.
• W2155210306 hasConcept C159654299 @default.
• W2155210306 hasConcept C203014093 @default.
• W2155210306 hasConcept C2776247216 @default.
• W2155210306 hasConcept C2776336681 @default.
• W2155210306 hasConcept C2781069245 @default.
• W2155210306 hasConcept C2781301800 @default.
• W2155210306 hasConcept C500558357 @default.
• W2155210306 hasConcept C71924100 @default.
• W2155210306 hasConceptScore W2155210306C126322002 @default.
• W2155210306 hasConceptScore W2155210306C142724271 @default.
• W2155210306 hasConceptScore W2155210306C147483822 @default.
• W2155210306 hasConceptScore W2155210306C159654299 @default.
• W2155210306 hasConceptScore W2155210306C203014093 @default.
• W2155210306 hasConceptScore W2155210306C2776247216 @default.
• W2155210306 hasConceptScore W2155210306C2776336681 @default.
• W2155210306 hasConceptScore W2155210306C2781069245 @default.
• W2155210306 hasConceptScore W2155210306C2781301800 @default.
• W2155210306 hasConceptScore W2155210306C500558357 @default.
• W2155210306 hasConceptScore W2155210306C71924100 @default.
• W2155210306 hasIssue "3" @default.
• W2155210306 hasLocation W21552103061 @default.
• W2155210306 hasLocation W21552103062 @default.
• W2155210306 hasOpenAccess W2155210306 @default.
• W2155210306 hasPrimaryLocation W21552103061 @default.
• W2155210306 hasRelatedWork W116412196 @default.
• W2155210306 hasRelatedWork W1999708490 @default.
• W2155210306 hasRelatedWork W2021248145 @default.
• W2155210306 hasRelatedWork W2040191638 @default.
• W2155210306 hasRelatedWork W2120316643 @default.
• W2155210306 hasRelatedWork W2403358233 @default.
• W2155210306 hasRelatedWork W2415138818 @default.
• W2155210306 hasRelatedWork W2418654200 @default.
• W2155210306 hasRelatedWork W2472347071 @default.
• W2155210306 hasRelatedWork W2992719450 @default.
• W2155210306 hasVolume "4" @default.
• W2155210306 isParatext "false" @default.
• W2155210306 isRetracted "false" @default.
• W2155210306 magId "2155210306" @default.
• W2155210306 workType "article" @default.